Use of data mining at the Food and Drug Administration (Q30982556)

28 June 2017

1 reference

title

Use of data mining at the Food and Drug Administration (English)

1 reference

28 June 2017

0 references

Taha Kass-Hout

30

0 references

author name string

Hesha J Duggirala

1

1 reference

28 June 2017

Joseph M Tonning

2

1 reference

28 June 2017

Ella Smith

3

1 reference

28 June 2017

Roselie A Bright

4

1 reference

28 June 2017

John D Baker

5

1 reference

28 June 2017

Robert Ball

6

1 reference

28 June 2017

Carlos Bell

7

1 reference

28 June 2017

Susan J Bright-Ponte

8

1 reference

28 June 2017

Taxiarchis Botsis

9

1 reference

28 June 2017

Khaled Bouri

10

1 reference

28 June 2017

Marc Boyer

11

1 reference

28 June 2017

Keith Burkhart

12

1 reference

28 June 2017

G Steven Condrey

13

1 reference

28 June 2017

James J Chen

14

1 reference

28 June 2017

Stuart Chirtel

15

1 reference

28 June 2017

Ross W Filice

16

1 reference

28 June 2017

Henry Francis

17

1 reference

28 June 2017

Hongying Jiang

18

1 reference

28 June 2017

Jonathan Levine

19

1 reference

28 June 2017

David Martin

20

1 reference

28 June 2017

Taiye Oladipo

21

1 reference

28 June 2017

Rene O'Neill

22

1 reference

28 June 2017

Lee Anne M Palmer

23

1 reference

28 June 2017

Antonio Paredes

24

1 reference

28 June 2017

George Rochester

25

1 reference

28 June 2017

Deborah Sholtes

26

1 reference

28 June 2017

Ana Szarfman

27

1 reference

28 June 2017

Hui-Lee Wong

28

1 reference

28 June 2017

Zhiheng Xu

29

1 reference

28 June 2017

23 July 2015

1 reference

Journal of the American Medical Informatics Association

28 June 2017

1 reference

28 June 2017

23

1 reference

28 June 2017

428-434

1 reference

28 June 2017

2

1 reference

A model for the future conduct of pharmacovigilance

28 June 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Quantitative signal detection using spontaneous ADR reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Pharmacovigilance in the 21st century: new systematic tools for an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Application of change point analysis to daily influenza-like illness emergency department visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

A METHOD FOR CLUSTER ANALYSIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Algorithms for the optimal identification of segment neighborhoods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Vaccine adverse event text mining system for extracting features from vaccine safety reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Perspectives on the use of data mining in pharmaco-vigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Atypical antipsychotics and pituitary tumors: a pharmacovigilance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Hepatotoxicity due to hydroxycut: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Automating case definitions using literature-based reasoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Digital drug safety surveillance: monitoring pharmaceutical products in twitter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Under-reporting of adverse drug reactions : a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Measuring the frequency of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Technology, governance and patient safety: systems issues in technology and patient safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Surveillance of medical device-related hazards and adverse events in hospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Estimates of medical device--associated adverse events from emergency departments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Automated support for pharmacovigilance: a proposed system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Incidence and short-term outcomes of primary and revision hip replacement in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Transforming health care delivery through consumer engagement, health data transparency, and patient-generated health information

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Detecting influenza epidemics using search engine query data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

Toward enhanced pharmacovigilance using patient-generated data on the internet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAMIA%2FOCV063

21 January 2018

Identifiers

DOI

10.1093/JAMIA/OCV063

1 reference

journals/jamia/DuggiralaTSBBBB16

28 June 2017

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference